AccutarBio
Shanghai
About AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery. AccutarBio's philosophy is to derive a data-driven principle that has the power of explaining physical and chemical nature of biological systems, which we harness to accelerate drug discoveries.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $76.6M
- Last round: Series Unknown (Jan 2021)
- Website: accutarbio.com
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/accutarbio-120552 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.